Valuation West Pharmaceutical Services, Inc.

Stocks

Market Closed - NYSE 23:00:03 20/10/2026 +03			5-day change	1st Jan Change
388.78 ^USD	+1.27%		+5.76%	+41.30%

10-20	West Pharmaceutical Services, Inc. Declares Dividend for the Fourth-Quarter Dividend, Payable on November 18, 2026	CI
10-20	West Pharmaceutical Services Raises Quarterly Dividend 18% to $0.26 a Share, Payable Nov. 18 to Holders as of Nov. 11.	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	34,744	17,424	26,053	23,723	19,795	27,361	-	-
Change	-	-49.85%	49.53%	-8.95%	-16.56%	38.22%	-	-
Enterprise Value (EV) ¹	34,744	16,738	25,406	23,441	19,206	26,857	26,387	26,019
Change	-	-51.82%	51.78%	-7.74%	-18.07%	39.84%	-1.75%	-1.39%
P/E	54.1x	30.4x	44.7x	49x	40.5x	45.3x	39.4x	35.2x
PBR	14.9x	6.5x	8.98x	8.83x	5.95x	8.66x	7.64x	6.8x
PEG	-	-2.8x	23.04x	-3.2x	27.09x	1.7x	2.6x	3x
Capitalization / Revenue	12.3x	6.04x	8.83x	8.2x	6.44x	8.11x	7.63x	7.09x
EV / Revenue	12.3x	5.8x	8.61x	8.1x	6.25x	7.96x	7.36x	6.74x
EV / EBITDA	39.3x	19x	30.7x	32.2x	24.2x	28.6x	25.4x	22.4x
EV / EBIT	45.6x	22x	36.8x	40.9x	30.9x	35.5x	31.1x	27.2x
EV / FCF	105x	38.1x	61.3x	84.8x	41x	62.4x	46.5x	35.9x
FCF Yield	0.95%	2.63%	1.63%	1.18%	2.44%	1.6%	2.15%	2.79%
Dividend per Share ²	0.69	0.74	0.78	0.82	0.85	0.9025	0.9729	1.118
Rate of return	0.15%	0.31%	0.22%	0.25%	0.31%	0.23%	0.25%	0.29%
EPS ²	8.67	7.73	7.88	6.69	6.79	8.575	9.865	11.04
Distribution rate	7.96%	9.57%	9.9%	12.3%	12.5%	10.5%	9.86%	10.1%
Net sales ¹	2,832	2,887	2,950	2,893	3,074	3,375	3,587	3,860
EBITDA ¹	884.7	882.6	827.9	728.2	793.8	939.3	1,040	1,159
EBIT ¹	762.4	762	690.6	572.8	622.4	757.1	848.8	957
Net income ¹	661.8	585.9	593.4	492.7	493.7	618.7	709.6	798.1
Net Debt ¹	-	-685.4	-647.1	-282	-588.5	-503.3	-973.5	-1,342
Reference price ²	469.01	235.35	352.12	327.56	275.14	388.78	388.78	388.78
Nbr of stocks (in thousands)	74,080	74,033	73,990	72,422	71,943	70,376	-	-
Announcement Date	2/17/22 A	2/16/23 A	2/15/24 A	2/13/25 A	2/12/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WEST PHARMACEUTICAL SERVICES, INC.	44.77x	7.86x	28.23x	0.24%	27.02B
ABBOTT LABORATORIES	30.7x	4.06x	15.71x	2.44%	180B
MEDTRONIC PLC	19.83x	3.46x	12.37x	3.06%	114B
STRYKER CORPORATION	23.23x	4.55x	15.85x	1.21%	114B
ESSILORLUXOTTICA	26.93x	2.64x	10.6x	2.68%	78.39B
CENCORA, INC.	18.65x	0.21x	13.46x	0.7%	64.88B
HOYA CORPORATION	31.09x	7.72x	19.92x	1.28%	54.02B
BECTON, DICKINSON AND COMPANY	36.76x	3.52x	12.05x	2.06%	51.96B
IDEXX LABORATORIES, INC.	37.64x	9.35x	26.14x	-.--%	43.79B
DEXCOM, INC.	34.55x	6.06x	19.02x	-.--%	32.45B
Average	30.42x	4.94x	17.34x	1.37%	76.04B
Weighted average by Cap.	28.04x	4.32x	15.75x	1.79%